In conclusion, the data presented above collectively indicate that PERK/ATF4 signaling can promote metastatic cancer spread by both increasing cell survival and directly upregulating the cellular enzymes involved in the cell migratory and invasive processes. The gene discussed is ATF4; the disease is cancer.